リチウムイオン

Lithium ion

HCID 28486CAS 17341-24-1

基本情報

標準SMILES
[Li+]
InChIKey
HBBGRARXTFLTSG-UHFFFAOYSA-N
分子式
Li+
平均分子量
7 g/mol
単同位体質量
7.01600343

名称と識別子

優先名称
Lithium ion
IUPAC
lithium(1+)
現地名
リチウムイオン
英語名
Lithium ion (1+)
分子式
Li+
分子量
6.94

名称と別名

lithium ionlithium cationLithium(1+)Lithium, ion (Li1+)17341-24-1lithium, ionLITHIUM ION CHROMATOGRAPHY STANDARDLi(+)8H8Z5UER66CHEBI:49713Lithium Monohydride;Lithium ions
名称をさらに表示
リチウムイオンリチウムカチオンリチウム(1+)イオンLithiumcationLithium ion (1+)LITHIUM ION STANDARDLITHIUM, ION CHROMATOGRAPHY STANDARD SOLUTION
Li+Lithium(+)UNII-8H8Z5UER66lithium(I)lithium(I) cationLithium (I) ionLi(+) cationLi(+) ion

データベース識別子

CAS
17341-24-1、7439-93-2
PubChem CID
28486
DTXSID
DTXSID10169612
ChEMBL
CHEMBL1234004
ChEBI
CHEBI:49713
UNII
8H8Z5UER66
Nikkaji
J247.008J

物性

構造計算による物性

極性表面積
0 Ų
水素結合供与体数
0
水素結合受容体数
0
回転可能結合数
0
重原子数
1

実験および物理化学的性質

SolubilityViolent reaction
Boiling Point1336
Melting Point · 2 件

180.5

190 °C

Physical DescriptionSolid

化学と産業

薬理情報

Pharmacodynamics · 1 件

Although lithium has been used for over 50 years in treatment of bipolar disorder, the mechanism of action is still unknown. Lithium's therapeutic action may be due to a number of effects, ranging from inhibition of enzymes such as glycogen synthase kinase 3, inositol phosphatases, or modulation of glutamate receptors.

Mechanism of Action · 1 件

The precise mechanism of action of Li+ as a mood-stabilizing agent is currently unknown. It is possible that Li+ produces its effects by interacting with the transport of monovalent or divalent cations in neurons. An increasing number of scientists have come to the conclusion that the excitatory neurotransmitter glutamate is the key factor in understanding how lithium works. Lithium has been shown to change the inward and outward currents of glutamate receptors (especially GluR3), without a shift in reversal potential. Lithium has been found to exert a dual effect on glutamate receptors, acting to keep the amount of glutamate active between cells at a stable, healthy level, neither too much nor too little. It is postulated that too much glutamate in the space between neurons causes mania, and too little, depression. Another mechanism by which lithium might help to regulate mood include the non-competitive inhibition of an enzyme called inositol monophosphatase. Alternately lithium's action may be enhanced through the deactivation of the GSK-3B enzyme. The regulation of GSK-3B by lithium may affect the circadian clock. GSK-3 is known for phosphorylating and thus inactivating glycogen synthase. GSK-3B has also been implicated in the control of cellular response to damaged DNA. GSK-3 normally phosphorylates beta catenin, which leads to beta catenin degratation. When GSK-3 is inhibited, beta catenin increases and transgenic mice with overexpression of beta catenin express similar behaviour to mice treated with lithium. These results suggest that increase of beta catenin may be a possible pathway for the therapeutic action of lithium.

FDA Pharmacological Classification · 4 件

8H8Z5UER66

LITHIUM CATION

Established Pharmacologic Class [EPC] - Mood Stabilizer

Lithium cation is a Mood Stabilizer.

サプライヤー26 社

山东泰诚生物科技有限公司18769832557 18769832557 · [email protected]
廊坊乾耀科技有限公司0316-2617888 17301291189 · [email protected]
山东海舟生物工程有限公司130-0567-0367 13006570367 · [email protected]
宁波化工原料有限公司13306607903;13306607903 · [email protected]
武汉绿景丰华生物科技有限公司19972070065 · [email protected]

関連反応

15,856 件

関連ノート

読み込み中…